BioCentury
ARTICLE | Company News

Vaccine candidate moves forward

February 15, 2000 8:00 AM UTC

BioChem Pharma (BCHE; TSE:BCH) and Biovector Therapeutics (Toulouse, France) will develop a nasal vaccine against Streptococcus pneumoniae using BCHE's protein antigen and Biovector's Light Biovector ...